Loading stock…

MNTN, Inc. (MNTN) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

MNTNMNTN

Revenue FY25$290M

GROWTH RATING↗

VERY STRONG89 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+29%10

Revenue, next 1Y+21%8

Revenue, next 3Y, CAGR+19%9

Revenue, next 5Y, CAGR+16%9

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+27%8

EPS growth, FY28E+23%8

GROWTH ASSESSMENT

STRENGTHS

It out-grows 89% of companies worldwide.

Revenue grew 29%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 19%/yr over the next 3 years, ahead of most of the market.9/10

The runway holds up: revenue is set to grow 16%/yr over five years.9/10

Earnings are set to grow in step with sales (EPS about 23%/yr vs revenue 19%/yr).

WATCH

Revenue grew 29%/yr over the last 3 years; forecasts see it cooling to 19%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK3 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-22%1

3-month return-8%4

YTD return-16%3

MID & LONG-TERM▾SCORE

% of 52-week high54%2

1-year return-43%1

3-year return-62%1

5-year return-62%1

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

Returns sit at the market level over three months (-8%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-62% over three years and -62% over five), behind 90% of the market.

It's down 43% over the past year, now 46% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-22%) and so far this year (-16%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on MNTN. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

MNTNMNTN

Revenue FY25$290M

GROWTH RATING↗

VERY STRONG89 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+29%10

Revenue, next 1Y+21%8

Revenue, next 3Y, CAGR+19%9

Revenue, next 5Y, CAGR+16%9

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+27%8

EPS growth, FY28E+23%8

GROWTH ASSESSMENT

STRENGTHS

It out-grows 89% of companies worldwide.

Revenue grew 29%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 19%/yr over the next 3 years, ahead of most of the market.9/10

The runway holds up: revenue is set to grow 16%/yr over five years.9/10

Earnings are set to grow in step with sales (EPS about 23%/yr vs revenue 19%/yr).

WATCH

Revenue grew 29%/yr over the last 3 years; forecasts see it cooling to 19%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK3 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-22%1

3-month return-8%4

YTD return-16%3

MID & LONG-TERM▾SCORE

% of 52-week high54%2

1-year return-43%1

3-year return-62%1

5-year return-62%1

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

Returns sit at the market level over three months (-8%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-62% over three years and -62% over five), behind 90% of the market.

It's down 43% over the past year, now 46% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-22%) and so far this year (-16%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on MNTN. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

MNTN, Inc.

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on MNTN. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on MNTN. Get the full investment case.

Premium